ICD Co., Ltd.

KOSDAQ 040910.KQ

ICD Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 1.43

ICD Co., Ltd. Price to Sales Ratio (P/S) is 1.43 on January 14, 2025, a -38.00% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

ICD Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 2.84 on April 08, 2024, which is 98.75% above the current Price to Sales Ratio (P/S).
ICD Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 0.96 on December 09, 2024, which is -33.10% below the current Price to Sales Ratio (P/S).
ICD Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 1.75.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

KOSDAQ: 040910.KQ

ICD Co., Ltd.

CEO	Mr. Seung-Ho Lee
IPO Date	Aug. 5, 2011
Location	South Korea
Headquarters	274, Manse-ro
Employees	313
Sector	Technology
Industries Semiconductors Chemicals & Advanced Materials Hardware & Electronics

Description

ICD Co., Ltd. engages in the manufacture and sale of LCD, semiconductor, and flat panel display equipment in South Korea and internationally. The company offers AMOLED equipment, including HDP etchers, dry etchers, plasma treatment systems, and evaporators; and TFT-LCD equipment comprising dry etchers and plasma ashers. It also provides parts, such as electrostatic chucks, high voltage DC generators, end point detectors, 3D glass forming systems, and surface treatment parts. The company was founded in 2000 and is headquartered in Anseong, South Korea.

Key trends

Past 5 years